Tutorials › Statistical Genetics › Extreme-Phenotype Sampling for Quantitative Traits

Genome-Wide Association Study Design · Tutorial 354 of 989

Extreme-Phenotype Sampling for Quantitative Traits

See how extreme-phenotype sampling boosts genotype contrasts and how to convert a tail-sample association into a population-scale quantitative-trait effect.

Intermediate 12 min read

What You'll Learn

  • Define upper- and lower-tail sampling for a quantitative trait
  • Calculate normal-theory tail cutoffs and conditional means
  • Derive the approximate genotype-dosage contrast between selected tails
  • Convert an observed tail-sample contrast to a population-scale effect
  • Identify assumptions and selection-related interpretation pitfalls

Why Sample From the Tails?

A genome-wide association study can recruit participants across the full range of a quantitative trait, or it can deliberately recruit people with unusually high and unusually low values. The second approach, often called extreme-phenotype sampling, concentrates recruitment where genetic differences may be easier to detect. If a variant shifts the trait upward, its dosage may be more frequent among people in the upper tail and less frequent among people in the lower tail.

This efficiency comes with a cost: the sampled participants no longer represent the trait distribution in the target population. The association observed in the tails therefore needs to be interpreted using the sampling design. In particular, the difference between the average trait values of the two selected groups is not itself an estimate of a genetic effect. The analysis must use genotype differences, a model that accounts for selection, or both.

Definition: In extreme-phenotype sampling, participants are selected because their measured quantitative-trait values lie in specified upper and/or lower portions of the trait distribution. For symmetric sampling, the upper and lower tails have the same population proportion. Participants between the cutoffs are not recruited for this sample.

Normal-Tail Quantities

Suppose the population trait \(Y\) is approximately normal with mean \(\mu\) and standard deviation \(\sigma_Y\). If the upper and lower tails each contain proportion \(q\), define \(c\) by \(P(Z>c)=q\), where \(Z\sim N(0,1)\). The cutoffs are then \(\mu+c\sigma_Y\) and \(\mu-c\sigma_Y\). The standard normal density and distribution functions are denoted by \(\phi\) and \(\Phi\).

For a standard normal variable, the mean above \(c\) is \(\lambda(c)=\phi(c)/[1-\Phi(c)]\). By symmetry, the mean below \(-c\) is \(-\lambda(c)\). Thus the selected upper and lower groups have a larger mean contrast than a random sample would typically show, even before considering genotype.

Result: If \(Y\sim N(\mu,\sigma_Y^2)\), then
$$ E(Y\mid Y>\mu+c\sigma_Y)=\mu+\sigma_Y\lambda(c),\qquad E(Y\mid Y<\mu-c\sigma_Y)=\mu-\sigma_Y\lambda(c), $$
where \(\lambda(c)=\phi(c)/[1-\Phi(c)]\). The expected trait-mean contrast between the selected tails is \(2\sigma_Y\lambda(c)\). This is a contrast created by selection, not a genetic effect.

Worked Example: Finding the Mean Trait Contrast in the Tails

Suppose a hypothetical trait has population mean 50 units and standard deviation 10 units. Researchers recruit the highest and lowest 5% of values. The standard normal cutoff for a 5% upper tail is approximately \(c=1.645\), and \(\lambda(1.645)\approx2.063\).

The trait cutoffs are \(50\pm1.645(10)\), giving a lower cutoff of 33.55 units and an upper cutoff of 66.45 units. The expected mean among the upper-tail participants is \(50+10(2.063)=70.63\) units. The expected mean among the lower-tail participants is \(50-10(2.063)=29.37\) units.

The selected-group mean contrast is \(70.63-29.37=41.26\) units, or \(4.126\) population standard deviations. This large contrast follows from selecting the tails; it does not imply that any genetic variant changes the trait by 41.26 units.

How Selection Enriches a Genotype Contrast

Consider a biallelic variant with allele frequency \(p\), and let \(G\) be the allele dosage, coded 0, 1, or 2. Under Hardy–Weinberg equilibrium, \(E(G)=2p\) and \(\operatorname{Var}(G)=2p(1-p)\). Suppose the trait follows an additive model: each additional effect allele changes the population mean by \(\beta\) trait units. Write \(b=\beta/\sigma_Y\) for the effect in standard-deviation units.

For the following approximation, assume the trait is approximately normal, the effect is small relative to \(\sigma_Y\), and the upper and lower thresholds are set at \(\mu\pm c\sigma_Y\). Also assume participants are sampled randomly within each tail. Under these conditions, a genotype dosage shifts the trait mean by approximately \(\beta(G-2p)\). The probability of entering the upper tail therefore changes with dosage; the lower-tail probability changes in the opposite direction.

Approximate result: The expected mean dosage difference between the upper and lower tails is
$$ E(G\mid\text{upper tail})-E(G\mid\text{lower tail}) \approx 2\lambda(c)\operatorname{Var}(G)b =4p(1-p)\lambda(c)\frac{\beta}{\sigma_Y}. $$
The result is an approximation for a small additive effect under the stated normal-tail model. It describes an expected difference in allele dosage per participant, not a difference in trait units.

Why the Dosage-Contrast Formula Holds

The approximation can be derived by expanding the tail probabilities for small \(b\). Let \(q=1-\Phi(c)\). For a person with dosage \(G\), the approximate standardized shift is \(b(G-2p)\). The probability of being above the upper cutoff is therefore \(1-\Phi\{c-b(G-2p)\}\). A first-order Taylor expansion around \(b=0\) gives \(q+\phi(c)b(G-2p)\). Similarly, the lower-tail probability is approximately \(q-\phi(c)b(G-2p)\).

To obtain the expected dosage among upper-tail participants, multiply each dosage by its upper-tail probability and average over the population genotype distribution. The constant part contributes \(qE(G)\), and the first-order part contributes \(\phi(c)b\operatorname{Var}(G)\). Dividing by the upper-tail probability, which is \(q\) to first order, gives an upper-tail mean dosage of approximately \(E(G)+\lambda(c)b\operatorname{Var}(G)\). The corresponding lower-tail mean is approximately \(E(G)-\lambda(c)b\operatorname{Var}(G)\). Subtracting yields \(2\lambda(c)b\operatorname{Var}(G)\), as stated.

The approximation shows why the allele frequency matters: when \(p\) is near 0 or 1, \(2p(1-p)\) is small, so there is less genotype variation to enrich. It also shows why more extreme cutoffs can produce a larger genotype contrast: \(\lambda(c)\) rises as the tails become more extreme. However, increasingly extreme sampling leaves fewer eligible people and can make recruitment or estimation less practical.

Worked Example: Converting a Tail Dosage Contrast to a Trait Effect

In a hypothetical study, participants are sampled from the highest and lowest 5% of a normally distributed trait. The effect-allele frequency is \(p=0.30\), and the estimated mean dosage is 0.140 alleles per person higher in the upper tail than in the lower tail. Estimate the population-scale additive effect in units of the trait standard deviation.

For these cutoffs, \(c=1.645\) and \(\lambda(c)\approx2.063\). The approximate conversion factor from the standardized effect \(b\) to the upper-minus-lower dosage difference is \(4p(1-p)\lambda(c)\). Substituting the values gives \(4(0.30)(0.70)(2.063)=1.733\), to three decimal places.

Consequently, the estimated standardized effect is \(b\approx0.140/1.733=0.0808\). Under the model and approximation, each additional effect allele is associated with an increase of about 0.0808 population standard deviations in the trait mean. If the population trait standard deviation were 12 units, the corresponding effect would be \(0.0808(12)=0.970\) trait units per allele. The interpretation is population-scale; it is not the trait-mean difference between the selected tails.

Planning and Analyzing an Extreme-Tail Sample

Extreme sampling is most useful when a study can define the target population and phenotype carefully, identify tail thresholds in a relevant reference distribution, and recruit enough people from both tails. The genotype association can be analyzed as a dosage contrast between the tails or with a model for the probability of tail membership. If the study uses a different sampling fraction from each tail, the sampling scheme must be reflected in the model; random sampling within each tail is a key condition for the simple contrast interpretation.

Here is a practical sequence for moving from design to interpretation:

1
Specify the population and trait scale.
Define who the study is intended to represent and how the quantitative trait is measured. The cutoffs and effect units must refer to this target population.
2
Set tail thresholds.
Use a suitable reference distribution to define the upper and lower cutoffs. Record the tail proportions and the corresponding standardized cutoff \(c\).
3
Recruit and analyze consistently.
Recruit participants according to the stated tail rules, and compare genotype dosage or fit a model that incorporates the selection design. Account for relevant covariates and recruitment structure.
4
Translate to the population scale.
For a small additive effect under the normal-tail assumptions, use the dosage-contrast relationship to express the effect per allele in trait standard deviations, then convert to trait units if \(\sigma_Y\) is known.

Worked Example: Interpreting a Tail-Sampled GWAS Estimate

A hypothetical source population contains 10,000 people. A study recruits 500 people from the upper 5% and 500 from the lower 5% of a trait with population standard deviation 12 units. At a variant with allele frequency 0.30, the observed upper-minus-lower mean dosage contrast is 0.140. Assume the small-effect normal-tail approximation is appropriate and participants were sampled randomly within each tail.

The study genotypes 1,000 people, rather than sampling 1,000 people across the full trait distribution. The relevant cutoff is \(c=1.645\), giving \(\lambda(c)\approx2.063\). As in the preceding calculation, the conversion factor is \(4(0.30)(0.70)(2.063)=1.733\), so the estimated standardized additive effect is \(0.140/1.733=0.0808\).

On the original trait scale, the estimate is \(0.0808(12)=0.970\) units per additional effect allele. This statement refers to the modeled population mean difference per allele. The study's selected participants have a deliberately exaggerated trait range, and their average trait values cannot be treated as representative population means. Nor does the estimate by itself establish a causal effect; it is an association under the model and design assumptions.

Assumptions and Common Pitfalls

The conversion is not a universal correction that can be applied regardless of design. It relies on approximate normality of the trait distribution near the thresholds, an additive genotype effect that is small relative to the trait variation, suitable allele-frequency and genotype-variance information, and correct identification of the population cutoffs. Population structure or differences between recruitment sites can create genotype differences that are not due to the trait effect. Reliable phenotype measurement and alignment between the recruited sample and target population remain important.

For larger effects, substantial departures from normality, or asymmetric sampling, the first-order approximation may be inaccurate. In those settings, use the specified genotype-specific selection probabilities or an appropriate likelihood that represents the actual ascertainment process. Inference also needs a valid standard error and testing procedure for the chosen analysis; enrichment of the expected signal does not remove sampling uncertainty or other sources of bias.

  • Mistake: treating the upper-minus-lower trait mean as the genetic effect. That contrast is large by construction. The correction is to estimate the genotype association and interpret it using a model that accounts for tail selection.
  • Mistake: applying the conversion factor without its assumptions. The factor depends on the tail cutoff, allele frequency, and normal, small-effect approximation. Check these inputs and use a more suitable selection model if they do not fit.
  • Mistake: interpreting a selected sample as a population-representative cohort. The proportions recruited from the two tails were set by design. They do not estimate the population prevalence of high or low trait values.
Key takeaway: Sampling both extremes can increase the expected genotype contrast per participant. A population-scale effect can be recovered approximately from that contrast when the tail thresholds, allele frequency, trait scale, and selection assumptions are correctly specified. The selected sample's trait means and tail proportions are not population summaries.

Check Your Understanding

Answer using the normal-tail and additive-effect assumptions stated above.

  1. For a normally distributed trait, what does \(\lambda(c)\) represent, and how does it determine the expected upper-tail mean?
  2. Why is the upper-minus-lower trait mean contrast not an estimate of a genetic effect?
  3. If \(p=0.50\), \(c=1.645\), and the standardized additive effect is \(b=0.05\), what upper-minus-lower genotype dosage contrast does the approximation predict?
  4. What information is needed to convert a standardized effect to the original trait units?
  5. Name two conditions under which the dosage-contrast conversion may be unreliable.
Clinical Biostats